title: Distribution study of cisplatin in rat kidney and liver cancer tissues by using liquid chromatography electrospray ionization tandem mass spectrometry.
abstract: A sensitive and rapid liquid chromatography positive ion electrospray ionization tandem mass spectrometric (LC/ESI-MS/MS) method has been developed and validated for the quantitative determination and distribution of cisplatin (CP) in kidney and liver tissues after intravenous administration of drug to adult male Sprague Dawley rats. Oxaliplatin (OXP) was used as an internal standard. The tissue samples were homogenized and extracted using conventional liquid-liquid extraction method with phosphate buffer containing ethyl acetate and then subjected to LC-MS analysis. The chromatographic separation was achieved on an Agilent ZORBAX SB C-18 column (50 × 2.1 mm, 1.8 µm) using the mobile phase consisting of 0.1% formic acid in water (Solvent A) : methanol (Solvent B) (40 : 60; v/v) in an isocratic elution followed by detection with positive ion electrospray ionization tandem mass spectrometry using the transitions of m/z 301 > 265 for CP and m/z 398 > 310 for OXP in multiple reaction monitoring mode. The calibration curve was linear in the range of 5.0-7000 and 10.0-6000 ng/ml for kidney and liver tissue homogenates, respectively. The method revealed good performances in terms of within-batch, between-batch precision (1.31-5.70%) and accuracy (97.0-102.24%) for CP in both kidney and liver tissue homogenates including lower and upper limits of quantification. The recoveries from spiked control samples were >81.0% and >87.0 % for CP and OXP, respectively. Matrix effect was found to be negligible, and the stability data were within the acceptable limits. Further, the validated LC/ES-MS/MS method was successfully applied to investigate the distribution of CP in kidney and liver tissues after intravenous administration of CP to male Sprague Dawley rats. The results showed that the higher amount of CP was distributed in kidney followed by liver, which indicated that CP mainly accumulated in kidney tissues and renal excretion might be a primary and main elimination route. This is the first research approach focused on the quantitative determination and distribution of CP in rat kidney and liver tissue homogenates by using LC/ESI-MS/MS, which could provide essential information for further pharmacological and clinical studies of CP.
authors.affiliation: Department of Applied Chemistry, College of Applied Sciences, Kyung Hee University, Yongin, 446-701, Korea.
authors.forename: Raju
authors.initials: R
authors.lastname: Bandu
authors.affiliation: Department of Applied Chemistry, College of Applied Sciences, Kyung Hee University, Yongin, 446-701, Korea.
authors.forename: Hyun Soo
authors.initials: HS
authors.lastname: Ahn
authors.affiliation: Department of Applied Chemistry, College of Applied Sciences, Kyung Hee University, Yongin, 446-701, Korea.
authors.forename: Joon Won
authors.initials: JW
authors.lastname: Lee
authors.affiliation: Department of Radiology, Pusan National University School of Medicine, Biomedical Research Institute, Pusan National University Yangsan Hospital, Yangsan, Korea.
authors.forename: Yong Woo
authors.identifier: http://orcid.org/0000-0003-0095-3787
authors.initials: YW
authors.lastname: Kim
authors.affiliation: Department of Radiology, Pusan National University School of Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
authors.forename: Seon Hee
authors.initials: SH
authors.lastname: Choi
authors.affiliation: Department of Radiology, Pusan National University School of Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
authors.forename: Hak Jin
authors.initials: HJ
authors.lastname: Kim
authors.affiliation: Department of Applied Chemistry, College of Applied Sciences, Kyung Hee University, Yongin, 446-701, Korea.
authors.forename: Kwang Pyo
authors.initials: KP
authors.lastname: Kim
mesh_terms: D000818:Animals; D002853:Chromatography, Liquid / Q000379:methods*; D002945:Cisplatin / Q000737:chemistry / Q000493:pharmacokinetics*; D007668:Kidney / Q000737:chemistry / Q000378:metabolism; D007680:Kidney Neoplasms / Q000737:chemistry* / Q000378:metabolism; D016014:Linear Models; D008099:Liver / Q000737:chemistry / Q000378:metabolism; D008113:Liver Neoplasms / Q000737:chemistry* / Q000378:metabolism; D008297:Male; D009944:Organoplatinum Compounds / Q000737:chemistry / Q000493:pharmacokinetics; D000077150:Oxaliplatin; D051381:Rats; D017207:Rats, Sprague-Dawley; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D053719:Tandem Mass Spectrometry / Q000379:methods*; D014018:Tissue Distribution
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D002945:Cisplatin
keywords: MRM; cisplatin; distribution study; kidney and liver tissues; oxaliplatin